| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Journal of Immunology, Vol 154, Issue 2 882-892, Copyright © 1995 by American Association of Immunologists
ARTICLES |
B Descamps-Latscha, A Herbelin, AT Nguyen, P Roux-Lombard, J Zingraff, A Moynot, C Verger, D Dahmane, D de Groote and P Jungers
INSERM Unit 25, Necker Hospital, Paris, France.
Patients with end-stage renal disease present an immunodeficiency that paradoxically coexists with activation of most immunocompetent cells, and the roles of chronic uremia and maintenance dialysis are poorly understood. We determined circulating levels of IL-1 beta and IL-1Ra, TNF-alpha and its soluble receptors (TNF-sR55 and TNF-sR75), and activation markers of T cells (soluble CD25), B cells (soluble CD23), and monocytes (neopterin) in a large cohort of undialyzed patients at various stages of chronic renal failure and in dialyzed patients on maintenance hemodialysis or chronic peritoneal dialysis. The progression of uremia was associated with a gradual increase in soluble CD25, CD23, and especially neopterin levels. Although IL-1 beta could not be detected, IL-1Ra levels were significantly increased from the earliest stage of renal failure. Plasma levels of TNF-alpha, TNF-sR55, and TNF-sR75 progressed with the severity of renal failure and correlated with soluble CD25, CD23, and neopterin levels, whereas IL- 1Ra levels correlated exclusively with TNF-sR55 levels. Compared with undialyzed patients, levels of IL-1 beta were higher in patients on maintenance hemodialysis, whereas those of IL-1Ra were lower and decreased further at the end of dialysis sessions. In contrast, both TNF-sR55 and TNF-sR75 levels were significantly higher than in undialyzed patients and increased further at the end of dialysis sessions in the absence of an increase of TNF-alpha. Such an imbalance between cytokines and their inhibitors may play a pivotal role in the multifaceted process of immune dysfunction.
This article has been cited by other articles:
|
|
 |
|
  B. Zhang, L. Li, L. Feng, Y. Zhang, X. Zeng, J. Feng, D. Yang, C. Zheng, and X. Yan Elevated Levels of Soluble and Neutrophil CD146 in Active Systemic Vasculitis Lab Med, June 1, 2009; 40(6): 351 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kino, H. Takatori, I. Manoli, Y. Wang, A. Tiulpakov, M. R. Blackman, Y. A. Su, G. P. Chrousos, A. H. DeCherney, and J. H. Segars Brx Mediates the Response of Lymphocytes to Osmotic Stress Through the Activation of NFAT5 Sci. Signal., February 10, 2009; 2(57): ra5 - ra5. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, May 13, 2008; 117(19): 2544 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Dursun, E. Dursun, G. Suleymanlar, B. Ozben, I. Capraz, A. Apaydin, and T. Ozben Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1697 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Cooker, D. Peterson, J. Rambow, M. L. Riser, R. E. Riser, F. Najmabadi, D. Brigstock, and B. L. Riser TNF-{alpha}, but not IFN-{gamma}, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis Am J Physiol Renal Physiol, July 1, 2007; 293(1): F157 - F165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bauvois, N. Mothu, J. Nguyen, T. Nguyen-Khoa, L.-H. Noel, and P. Jungers Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-{beta}1 in patients with distinct types of primary glomerulonephritis Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1115 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goncalves, R. Pecoits-Filho, S. Perreto, S. H. Barberato, A. E. M. Stinghen, E. G. A. Lima, R. Fuerbringer, S. M. Sauthier, and M. C. Riella Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2788 - 2794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Wozniacka, A Lesiak, J Narbutt, D P McCauliffe, and A Sysa-Jedrzejowska Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients Lupus, May 1, 2006; 15(5): 268 - 275. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Ohtake, S. Kobayashi, H. Moriya, K. Negishi, K. Okamoto, K. Maesato, and S. Saito High Prevalence of Occult Coronary Artery Stenosis in Patients with Chronic Kidney Disease at the Initiation of Renal Replacement Therapy: An Angiographic Examination J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1141 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Hou, H. Ren, W. F. Owen Jr, Z. J. Guo, P. Y. Chen, A. M. Schmidt, T. Miyata, and X. Zhang Enhanced Expression of Receptor for Advanced Glycation End Products in Chronic Kidney Disease J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1889 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. T. Yu Progression of Chronic Renal Failure Arch Intern Med, June 23, 2003; 163(12): 1417 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pecoits-Filho, B. Lindholm, J. Axelsson, and P. Stenvinkel Update on interleukin-6 and its role in chronic renal failure Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1042 - 1045. [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Fried, M. G. Shlipak, C. Crump, A. J. Bleyer, J. S. Gottdiener, R. A. Kronmal, L. H. Kuller, and A. B. Newman Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1364 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Mange, M. M. Joffe, and H. I. Feldman Dialysis prior to living donor kidney transplantation and rates of acute rejection Nephrol. Dial. Transplant., January 1, 2003; 18(1): 172 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Malaponte, V. Bevelacqua, P. Fatuzzo, F. Rapisarda, G. Emmanuele, S. Travali, and M. C. Mazzarino IL-1{beta}, TNF-{alpha} and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1964 - 1970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schratzberger and G. Mayer Chronic allograft failure: a disease we don't understand and can't cure? Nephrol. Dial. Transplant., August 1, 2002; 17(8): 1384 - 1390. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Reis, M. B. Olson, L. Fried, V. Reeser, S. Mankad, C. J. Pepine, R. Kerensky, C. N. B. Merz, B. L. Sharaf, G. Sopko, et al. Mild Renal Insufficiency Is Associated With Angiographic Coronary Artery Disease in Women Circulation, June 18, 2002; 105(24): 2826 - 2829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Baker, M. A. Armstrong, S. J. Allen, and W. T. McBride Editorial II: Role of the kidney in perioperative inflammatory responses Br. J. Anaesth., March 1, 2002; 88(3): 330 - 334. [Full Text] [PDF]
|
|
|
|
|
|
R. Schindler, R. Senf, and U. Frei Influencing the inflammatory response of haemodialysis patients by cytokine elimination using large-pore membranes Nephrol. Dial. Transplant., January 1, 2002; 17(1): 17 - 19. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Qureshi, A. Alvestrand, J. C. Divino-Filho, A. Gutierrez, O. Heimburger, B. Lindholm, and J. Bergstrom Inflammation, Malnutrition, and Cardiac Disease as Predictors of Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S28 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Canaud, V. Wizemann, F. Pizzarelli, R. Greenwood, G. Schultze, C. Weber, and D. Falkenhagen Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2181 - 2187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. C. van Riemsdijk-van Overbeeke, C. C. Baan, C. J. Knoop, E. H. M. Loonen, R. Zietse, and W. Weimar Quantitative flow cytometry shows activation of the TNF-{{alpha}} system but not of the IL-2 system at the single cell level in renal replacement therapy Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1430 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Mange, M. M. Joffe, and H. I. Feldman Effect of the Use or Nonuse of Long-Term Dialysis on the Subsequent Survival of Renal Transplants from Living Donors N. Engl. J. Med., March 8, 2001; 344(10): 726 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Airaghi, L. Garofalo, M. G. Cutuli, R. Delgado, A. Carlin, M. T. Demitri, S. Badalamenti, G. Graziani, J. M. Lipton, and A. Catania Plasma concentrations of {alpha}-melanocyte-stimulating hormone are elevated in patients on chronic haemodialysis Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1212 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sester, M. Sester, M. Hauk, H. Kaul, H. Kohler, and M. Girndt T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1217 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Noris and G. Remuzzi Uremic Bleeding: Closing the Circle After 30 Years of Controversies? Blood, October 15, 1999; 94(8): 2569 - 2574. [Full Text] [PDF]
|
|
|
|
|
|
Y. Le Meur, V. Lorgeot, J.-C. Aldigier, J. Wijdenes, C. Leroux-Robert, and V. Praloran Whole blood production of monocytic cytokines (IL-1{beta}, IL-6, TNF-{alpha}, sIL-6R, IL-1Ra) in haemodialysed patients Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2420 - 2426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Witko-Sarsat, M. Friedlander, T. N. Khoa, C. Capeillere-Blandin, A. T. Nguyen, S. Canteloup, J.-M. Dayer, P. Jungers, T. Drueke, and B. Descamps-Latscha Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure1, 2 J. Immunol., September 1, 1998; 161(5): 2524 - 2532. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
